Demant A/S (WILYY) Stock Price, News & Analysis

Company Overview

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division. The group also offers accessories and wireless connectivity products that integrate with smartphones and assistive listening devices. Demant’s focus on research and innovation is reflected in its investment in digital platforms and signal-processing technologies aimed at improving speech clarity and user comfort.

Headquartered in Smørum, Denmark, Demant serves customers in more than 130 countries through a network of subsidiaries, distributors and partner clinics. The company operates manufacturing facilities across Europe and Asia, and maintains regional offices in North America and the Asia Pacific to support local markets. Its global presence allows Demant to address diverse regulatory environments and cater to a wide range of clinical practices and consumer preferences.

Founded in 1904 by entrepreneur Hans Demant under the Oticon name, the company was reorganized into the Demant Group and publicly listed in 1995. Over its history, Demant has grown through strategic acquisitions and internal development, reinforcing its position in the hearing health industry. The organization is led by President & CEO Søren Nielsen, supported by an executive leadership team that oversees ongoing innovation, quality assurance and expansion into emerging markets.

Key Stats

• Today's Range: $20.05 to $20.05
• 50-Day Range: $13.45 to $20.05
• 52-Week Range: $13.45 to $21.93
• Volume: 318 shs
• Average Volume: 231 shs
• Market Capitalization: $8.49 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Demant A/S Stock Analysis - MarketRank™

Demant A/S scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Demant A/S has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Demant A/S has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Demant A/S has a P/B Ratio of 5.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Demant A/S has been sold short.

Short Interest Ratio / Days to Cover

Demant A/S has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Demant A/S has recently increased by 2,231.03%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Demant A/S does not currently pay a dividend.

Dividend Growth

Demant A/S does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Demant A/S has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Demant A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Demant A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

Demant A/S has minimal institutional ownership at this time.

Company Calendar

• Today: 6/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WILYY
• Previous Symbol: NASDAQ:WILYY
• CIK: N/A
• Web: www.demant.com
• Phone: (453) 917-7300
• Fax: 45-3927-8900
• Employees: 26,704
• Year Founded: 1904

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.65
• Current Ratio: 1.36
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $3.48 billion
• Price / Sales: 2.44
• Cash Flow: $0.89 per share
• Price / Cash Flow: 22.41
• Book Value: $3.51 per share
• Price / Book: 5.71

Miscellaneous

• Outstanding Shares: 423,510,000
• Free Float: N/A
• Market Cap: $8.49 billion
• Optionable: Not Optionable
• Beta: 1.20